Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
Andreas Josting(Goethe University Frankfurt), Andreas Engert(University of Cologne), John Raemaekers(Radboud University Nijmegen), D Dejong(Goethe University Frankfurt), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas Fischer(University Hospital Magdeburg), Peter Borchmann(University of Cologne), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Igor Aurer(University Hospital Centre Zagreb), Hartmut Döhner(University Hospital Ulm), Martin‐Leo Hansmann(Goethe University Frankfurt), Jan Peter Glossmann(Goethe University Frankfurt), Volker Diehl(University of Cologne), Horst Müller(Goethe University Frankfurt), Kerstin Schäfer‐Eckart(Nuremberg Hospital), Joke W. Baars(The Netherlands Cancer Institute), Norbert Schmitz(University Hospital Münster), Lenka Šmardová(Johannes Gutenberg University Mainz), Bernd Metzner(Klinikum Oldenburg)
Cited by 163
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k